{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Jiang W"],"funding":["Kuanren Talents Program of the Second Affiliated Hospital of Chongqing Medical University","Postdoctoral Science Foundation of China","Innovation Project of Chongqing Postgraduate Research","High-level Medical Reserved Personnel Training Project of Chongqing","National Natural Science Foundation of China","Research and Frontier Exploration Key Project of Chongqing Science and Technology Commission"],"pagination":["e2204989"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9896067"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["10(4)"],"pubmed_abstract":["The emergence of aggregation-induced emission luminogens (AIEgens) has attracted substantial scientific attention. However, their antitumor efficacy in photodynamic therapy (PDT) is significantly restricted by the poor water solubility and limited treatment depth. Therefore, a novel AIEgens-involved therapeutic platform with good permeability and bioavailability is urgently required. Herein, supramolecular chemistry is combined with the AIEgen bis-pyrene (BP) to construct a peptide-AIEgen hybrid nanosystem (PAHN). After intravenous injection, the versatile nanoplatform not only improved the hydrophilicity of BP but also achieved stratified targeting from tumor to mitochondrial and induced mitochondrial dysfunction, thus activating caspase-3 upregulation. Then, sonodynamic therapy (SDT), an"],"journal":["Advanced science (Weinheim, Baden-Wurttemberg, Germany)"],"pubmed_title":["Peptide Supramolecular Assembly-Instructed In Situ Self-Aggregation for Stratified Targeting Sonodynamic Therapy Enhancement of AIE Luminogens."],"pmcid":["PMC9896067"],"funding_grant_id":["KR2019G001","CYB20154","2022TQ0396","2020GDRC011","W0026","cstc2019jcyj-zdxmX0020","81873901","82171946"],"pubmed_authors":["Cheng C","Guo X","Chen L","Xie Z","Li P","Wang J","Zhou Z","Qiu X","Jiang W","Ran H","Ren J","Luo Y","Wang Z"],"additional_accession":[]},"is_claimable":false,"name":"Peptide Supramolecular Assembly-Instructed In Situ Self-Aggregation for Stratified Targeting Sonodynamic Therapy Enhancement of AIE Luminogens.","description":"The emergence of aggregation-induced emission luminogens (AIEgens) has attracted substantial scientific attention. However, their antitumor efficacy in photodynamic therapy (PDT) is significantly restricted by the poor water solubility and limited treatment depth. Therefore, a novel AIEgens-involved therapeutic platform with good permeability and bioavailability is urgently required. Herein, supramolecular chemistry is combined with the AIEgen bis-pyrene (BP) to construct a peptide-AIEgen hybrid nanosystem (PAHN). After intravenous injection, the versatile nanoplatform not only improved the hydrophilicity of BP but also achieved stratified targeting from tumor to mitochondrial and induced mitochondrial dysfunction, thus activating caspase-3 upregulation. Then, sonodynamic therapy (SDT), an","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Feb","modification":"2026-03-31T11:00:06.428Z","creation":"2025-04-19T13:32:59.981Z"},"accession":"S-EPMC9896067","cross_references":{"pubmed":["36494092"],"doi":["10.1002/advs.202204989"]}}